Search results
Planet Fitness membership increases from $10/month for first time since 1998
The Republican· 15 hours agoPlanet Fitness, the nation’s largest gym chain, is increasing its monthly membership fee for the...
NanoViricides CEO discusses NV-387’s broad-spectrum antiviral potential
Proactive Investors· 2 days agoNanoViricides (NYSE-A:NNVC) has released a slew of new data supporting the safety and ultra-broad...
NanoViricides to showcase lead drug asset’s progress at global conference
Proactive Investors· 5 days agoNanoViricides (NYSE-A:NNVC) announced that members of its leadership team will be attending the EF...
Top Stock Movers Now: TSMC, Moderna, Sweetgreen, and More
Investopedia· 5 days agoU.S. equities were mixed at midday, as the markets reacted to corporate headlines and report showing...
Markets News, May 13, 2024: Stocks End Mixed As Investors Await Key Inflation Data; Dow's Winning...
Investopedia· 1 day agoIncyte's CEO said the repurchase authorization reflects the firm's strong confidence in its...
Moderna Stock Seesaws After The FDA Throws It A Curveball
Investor's Business Daily· 5 days agoThe FDA was due to make a decision by May 12. Moderna emphasized the FDA has not said it found any...
Bull Market and Beyond: 2 Stocks Just Waiting to Soar | The Motley Fool
The Motley Fool· 2 days agoLet's consider two such stocks: Moderna (MRNA 7.13%) and DexCom (DXCM -1.65%). Moderna is one of the...
New 'FLiRT' COVID variants spreading quickly across U.S. What are the symptoms?
Palm Beach Daily News via Yahoo News· 7 days agoNausea or vomiting, mild diarrhea Some people with COVID are asymptomatic and never display any symptoms, although they can still pass it to others. And many people with COVID have mild symptoms ...
Moderna’s mRNA Dreams Meet Reality With First Post-Covid Shot
Bloomberg· 6 days agoThe biotech’s lackluster new RSV vaccine undercuts the promise of mRNA to revolutionize health care....
Trending: Moderna's Proposed RSV Vaccine Faces Delayed FDA Review
Morningstar· 5 days ago13:53 ET -- Moderna is one of the most mentioned companies in the U.S. across all news items in the past 12 hours, according to Factiva data. The company said that the U.S. Food and Drug Administration won't meet the target action date of May 12 for